Airway tissue mast cells in persistent asthma: Predictor of treatment failure when patients discontinue inhaled corticosteroids

Chest

Volumn 124, Issue 1, 2003, Pages 42-50

  Kraft, Monica ^a   Martin, Richard J ^a   Lazarus, Stephen C ^b   Fahy, John V ^b   Boushey, Homer A ^b   Lemanske Jr , Robert F ^c   Szefler, Stanley J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Asthma; Bronchoscopy; Mast cell

Indexed keywords

CORTICOSTEROID; PLACEBO; SALMETEROL XINAFOATE; TRIAMCINOLONE ACETONIDE; TRYPTASE;

ADULT; ALLERGIC ASTHMA; ARTICLE; BRONCHOSCOPY; CELL STRUCTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG BIOPSY; MACROPHAGE; MAST CELL; MULTICENTER STUDY; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; TREATMENT OUTCOME; UNITED STATES;

EID: 0037484793     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.1.42     Document Type: Article

References (31)

1. Djukanovic R, Roche WR, Wilson JW, et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-457
2. National Heart, Lung and Blood Institute. Expert panel report 1: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991
3. Djukanovic R, Wilson JN, Britten KN, et al. Effect of inhaled corticosteroids on airway inflammation and symptoms of asthma. Am Rev Respir Dis 1992; 145:669-674
4. Gibson PG, Saltos N, Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid treated asthma. J Allergy Clin Immunol 2000; 105:752-759
5. Sont J, van Krieken J, Evertse C, et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax 1996; 51:496-502
6. Bingham CO, Austen KF. Mast-cell responses in the development of asthma. J Allergy Clin Immunol 2000; 105:S527-S534
7. Gauvreau GM, Lee JM, Watson RM, et al. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000; 161:1473-1478
8. Busse WW, Lamanske RF, Jr. Asthma. N Engl J Med 2001; 344:350-362
9. Lazarus SC, Boushey HA, Fahy JV, et al. Long-acting β-agonists in patients with persistent asthma: I. Monotherapy? National Heart, Lung, and Blood Institute's Asthma Clinical Research Network. JAMA 2001; 285:2583-2594
10. American Thoracic Society, Board of Directors. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD). Am Rev Respir Dis 1987; 136:225-244
11. Tashkin DP, Altose MD, Bleecker ER, et al. The Lung Health Study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. Am Rev Respir Dis 1992; 145:301-310
12. Fish JE, Peters SP, Chambers CV, et al. An evaluation of colchicine as an alternative to inhaled corticosteroids in moderate asthma. Am J Respir Crit Care Med 1997; 156: 1165-1171
13. Kraft M, Bettinger CM, Wenzel SE, et al. Methacholine challenge does not affect bronchoalveolar fluid cell number and many indices of cell function in asthma. Eur Respir J 1995; 8:1966-1971
14. Langmack EL, Martin RJ, Rex MD, et al. Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy. Chest 2000; 117:1055-1060
15. Britten KM, Howarth PH, Roche WR. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biotech Histochem 1990; 5:271-280
16. Gunderson HJG. Stereology of arbitrary particles: a review of unbiased number and size estimators and the presentation of some new methods. J Microsc 1986; 122:235-237
17. Cruz-Olive JM, Weibel ER. Sample designs for stereology. J Microsc 1981; 122:235-257
18. Baddeley AJ, Gundersen HJG, Cruz-Olive LM. Estimation of surface area from vertical sections. J Microsc 1986; 142:259-276
19. Wenzel SE, Fowler AA, Schwartz LB. Activation of pulmonary mast cells by bronchoalveolar allergen challenge: in vivo release of histamine in atopic subjects. Am Rev Respir Dis 1988; 137:1002-1008
20. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147:697-704
21. Smith TJ, Weis JH. Mucosal T cells and mast cells share common adhesion receptors. Immunol Today 1996; 17:60-63
22. Tisala S, Paavonen T, Renkonen R. aEβ7 and a4β7 integrins associated with intraepithelial and mucosal homing are expressed on macrophages. Eur J Immunol 1995; 25:411-417
23. Karlsson MG, Hellquist HB. Endothelial adhesion molecules for nasal homing T cells in allergy. Virchows Arch 1996; 429:49-54
24. Gruber BL, Kew RR, Jelaska A, et al. Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis. J Immunol 1996; 158:2310-2317
25. Gruber BL, Marchese MJ, Suzuki K, et al. Synovial procollagenase activation by human mast cell tryptase, dependence upon matrix metalloproteinase 3 activation. J Clin Invest 1989; 84:1657-1662
26. Schwartz LB. Tryptase: a clinical indicator of mast cell dependent events. Allergy Proc 1994; 15:119-123
27. Bradding P, Feather IH, Wilson S, et al. Immunolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects: the mast cells as a source of IL-4, IL-5 and IL-6 in human allergic mucosal inflammation. J Immunol 1993; 151:3853-3865
28. Burd PR, Thompson WC, Max EE, et al. Activated mast cells produce interleukin-13. J Exp Med 1995; 181:1373-1380
29. National Asthma Education and Prevention Program. Expert panel report 2. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997
30. Leuppi JD, Salome DM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroid. Am J Respir Crit Care Med 2001; 163:406-412
31. Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathological outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment: The AMPUL study group. Am J Respir Crit Care Med 1999; 159:1043-1051